Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2009/091/000958
CTRI/2009/091/000958
Completed
Phase 4

An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.

Cipla Ltd0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Cipla Ltd
Enrollment
30
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Cipla Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\. Children whose parents are willing to sign written informed consent
  • •2\. Children between 1 to 5 years of age
  • •3\.Children who are healthy or who have mild asthma

Exclusion Criteria

  • •1\. Children already using Baby Mask with valve (Cipla Ltd), prior to start of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Subjects with mild Asthma or COPD or healthy volunteer.
CTRI/2014/03/004448Cipla Ltd30
Completed
Phase 4
Study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPDHealth Condition 1: null- subjects with mild asthma or COPD
CTRI/2014/02/004432Cipla Ltd30
Completed
Phase 4
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat-V spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Healthy volunteers and subjects with mild Asthma orCOPD.
CTRI/2014/03/004462Cipla Ltd30
Completed
Phase 4
A clinical trial to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.
CTRI/2009/091/000586Cipla Ltd30
Active, not recruiting
Phase 1
Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABAS
EUCTR2017-004608-22-FRCHU de Nice28